ExodusPoint Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-80,670
| Closed | -$282K | – | 1550 |
|
|
2024
Q3 | $282K | Buy |
+80,670
| New | +$282K | ﹤0.01% | 1276 |
|
|
2024
Q1 | – | Sell |
-31,185
| Closed | -$117K | – | 1501 |
|
|
2023
Q4 | $117K | Buy |
31,185
+12,154
| +64% | +$45.6K | ﹤0.01% | 1271 |
|
|
2023
Q3 | $40K | Sell |
19,031
-5,220
| -22% | -$11K | ﹤0.01% | 1571 |
|
|
2023
Q2 | $115K | Sell |
24,251
-72,984
| -75% | -$346K | ﹤0.01% | 1658 |
|
|
2023
Q1 | $554K | Sell |
97,235
-148,523
| -60% | -$846K | ﹤0.01% | 1215 |
|
|
2022
Q4 | $2.48M | Buy |
245,758
+220,284
| +865% | +$2.22M | 0.04% | 547 |
|
|
2022
Q3 | $571K | Buy |
+25,474
| New | +$571K | 0.01% | 1288 |
|
|
2021
Q4 | – | Sell |
-13,686
| Closed | -$811K | – | 2238 |
|
|
2021
Q3 | $811K | Buy |
13,686
+3,666
| +37% | +$217K | 0.01% | 1079 |
|
|
2021
Q2 | $870K | Buy |
+10,020
| New | +$870K | 0.01% | 1011 |
|
|
2021
Q1 | – | Sell |
-13,651
| Closed | -$1.24M | – | 2185 |
|
|
2020
Q4 | $1.24M | Buy |
+13,651
| New | +$1.24M | 0.01% | 693 |
|
|
2020
Q2 | – | Sell |
-12,014
| Closed | -$267K | – | 1811 |
|
|
2020
Q1 | $267K | Buy |
+12,014
| New | +$267K | 0.01% | 649 |
|